Hemolytic anemia related to cold aglutine in a patient with systemic lupus erythematosus
PDF
Cite
Share
Request
Case Report
P: 137-139
December 2021

Hemolytic anemia related to cold aglutine in a patient with systemic lupus erythematosus

J Turk Soc Rheumatol 2021;13(3):137-139
1. Akdeniz Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Romatoloji Bilim Dalı, Antalya, Türkiye
2. Akdeniz Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Hematoloji Bilim Dalı, Antalya, Türkiye
No information available.
No information available
Received Date: 23.02.2021
Accepted Date: 06.10.2021
Publish Date: 22.12.2021
PDF
Cite
Share
Request

ABSTRACT

Systemic lupus erythematosus (SLE) is a well-known disease characterized by autoimmune chronic inflammation and autoantibodies. Autoimmune hemolytic anemia (AHA) may develop in <10% of SLE patients due to these autoantibodies. SLE-related AHAs usually develop through warm-type antibodies. Cold antibodymediated haemolytic anemia in SLE is extremely rare and generally unresponsive to glucocorticoid therapy. In this article, a SLE case with cold agglutinin hemolytic anemia, who responded well to steroid treatment, is presented.

References

1Giannouli S, Voulgarelis M, Ziakas PD, Tzioufas AG. Anemia in systemic lupus erythematosus: from pathophysiology to clinical assessment. Ann Rheum Dis 2006;65:144-8.
2Pirofsky B. Immune haemolytic disease: the autoimmune haemolytic anaemias. Clin Haematol 1975;4:167-80.
3Zaja F, Russo D, Fuga G, et al. Rituximab in a case of cold agglutinin, disease. Br J Haematol 2001;115:232-3.
44 Berentsen S, Tjonnfjord GE, Brudevold R, et al. Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease. Br J Haematol 2001;115:79-83.
5Srinivasan N, Oswal A, Garg S, Nahar J, Gosmonova A, Nahar R. Cold agglutinin induced hemolysis in a newly diagnosed systemic lupus erythematosus. Am J Med Sci 2010;339:270-3.
6Honne K, Nagashima T, Iwamoto M, Kamesaki T, Minota S. Glucocorticoid-responsive cold agglutinin disease in a patient with rheumatoid arthritis. Case Rep Rheumatol 2015;2015:823563. doi: 10.1155/2015/823563.
7Oshima M, Maeda H, Morimoto K, Doi M, Kuwabara M. Low-titer cold agglutinin disease with systemic sclerosis. Intern Med 2004;43:139-42.
8Nakamura H, Kamiya-Matsumoto K, Kawakami A, et al. A case of cold agglutinin disease in the course of treatment for polymyalgia rheumatica. Mod Rheumatol 2009;19:427-30.
9Guzzini F, Banfi L, Camerone G, Florio G, Garelli S. Cold agglutinin hemolytic anemia in a patient with adult-onset Still’s disease. Haematologica 1990;75:467-9.
10Jacobs J, Eichbaum Q. COVID-19 associated with severe autoimmune hemolytic anemia. Transfusion 2021;61:635-40.
11Kotani T, Takeuchi T, Kawasaki Y, et al. Successful treatment of cold agglutinin disease with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus. Lupus 2006;15:683-5.
Article is only available in PDF format. Show PDF
2024 ©️ Galenos Publishing House